# Aevum Longevity Corp. — Form D

Aevum Longevity Corp. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2025-07-09. The offering totals $2K, of which $2K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-07-09
- Form: D
- Accession: 0002076042-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2K
- Amount sold: $2K
- Investors: 4
- Date of first sale: 2025-07-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-551126

## Issuer

- Name: Aevum Longevity Corp.
- CIK: 0002076042
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Incorporated: 2023
- Address: 2501 - 550 BURRARD STREET, VANCOUVER, A1, V6C 2B5
- Phone: 604-868-1669

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Amandeep Gill | Director | Vancouver, A1 |
| Robert Payment | Director | Vancouver, A1 |

## More

- [CIK 2076042 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2076042&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002076042-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.